1. Academic Validation
  2. Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system

Evaluating variations in bilirubin glucuronidation activity by protease inhibitors in canine and human primary hepatocytes cultured in a 3D culture system

  • Toxicol In Vitro. 2023 Sep 1;105689. doi: 10.1016/j.tiv.2023.105689.
Hisayoshi Omori 1 Junko Chikamoto 2 Megumi Nagahara 3 Maki Hirata 3 Takeshige Otoi 4
Affiliations

Affiliations

  • 1 Bio-Innovation Research Center, Tokushima University, Tokushima, Japan; Preclinical Basic Research, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan.
  • 2 Preclinical Basic Research, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan.
  • 3 Bio-Innovation Research Center, Tokushima University, Tokushima, Japan; Faculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
  • 4 Bio-Innovation Research Center, Tokushima University, Tokushima, Japan; Faculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan. Electronic address: otoi@tokushima-u.ac.jp.
Abstract

Bilirubin is excreted into the bile from hepatocytes, mainly as monoglucuronosyl and bisglucuronosyl conjugates, reflecting bilirubin glucuronidation activity. However, there is limited information on the in vitro evaluation of liver cell lines or primary hepatocytes. This study aimed to investigate variations in the bilirubin metabolic function of canine and human hepatocyte spheroids formed in a three-dimensional (3D) culture system indicated by the formation of bilirubin glucuronides when Protease Inhibitors such as atazanavir, indinavir, ritonavir, and nelfinavir were treated with bilirubin. The culture supernatant was collected for bilirubin glucuronidation assessment and the cells were used to evaluate viability. On day 8 of culture, both canine and human hepatocyte spheroids showed high albumin secretion and distinct spheroid formation, and their bilirubin glucuronidation activities were evaluated considering cell viability. Treatment with atazanavir and ritonavir remarkably inhibited bilirubin glucuronide formation, wherein atazanavir showed the highest inhibition, particularly in human hepatocyte spheroids. These results may reflect the effects on cellular uptake of bilirubin and its intracellular metabolic function. Thus, primary hepatocytes cultured in a 3D culture system may be a useful in vitro system for the comprehensive evaluation of bilirubin metabolic function and risk assessment in bilirubin metabolic disorders for drug development.

Keywords

Bilirubin glucuronidation; Canine; Human; Primary hepatocyte; Spheroid.

Figures
Products